Suspension of trading
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2024-12-02 EST
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 25-07-01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 25-07-01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.37M 1.29M 1.18M 2.2M 149M 2.21M 15.45M 5.99M 76.11M 5.85M 5.72M 247M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.44M -26.71M -24.45M -45.65M -3.1B -45.99M -321M -124M -1.58B -122M -119M -5.12B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 2017-03-31 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-30 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 2018-11-30 |
Dan Kisner
BRD | Director/Board Member | 79 | 2019-06-06 |
William LaRue
BRD | Director/Board Member | 75 | 2017-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/20/24 | Free | Director | 2,200 | 0.0743% | ||
| 6/20/24 | Free | Director | 2,200 | 0.0743% | ||
| 6/20/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.52% | 1.56M | |
| -0.18% | +4.58% | +3.88% | +31.79% | 47.86B | |
| -0.83% | -0.67% | +42.61% | +34.77% | 44.46B | |
| -0.84% | +5.34% | +8.05% | +91.52% | 41.85B | |
| -1.10% | -6.89% | +329.50% | +535.80% | 41.34B | |
| -0.62% | -0.06% | +10.15% | +46.02% | 30.04B | |
| -2.07% | -0.54% | +23.90% | +154.30% | 17.59B | |
| -6.08% | -6.94% | - | - | 15.6B | |
| -3.55% | +3.65% | +21.51% | +38.83% | 15.69B | |
| -0.78% | +11.24% | -10.81% | - | 13.93B | |
| Average | -3.86% | -0.19% | +47.64% | +105.19% | 26.84B | |
| Weighted average by Cap. | -1.09% | +1.88% | +67.06% | +141.32% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.31M 1.23M 1.13M 2.1M 143M 2.12M 14.77M 5.72M 72.76M 5.59M 5.47M 236M | 785K 690K 648K 593K 1.11M 75.15M 1.12M 7.78M 3.01M 38.33M 2.95M 2.88M 124M |
| Net income | -44.17M -38.8M -36.43M -33.36M -62.28M -4.23B -62.74M -438M -170M -2.16B -166M -162M -6.99B | -39.48M -34.68M -32.56M -29.81M -55.66M -3.78B -56.08M -391M -152M -1.93B -148M -145M -6.25B |
| Net Debt | -63.64M -55.9M -52.49M -48.06M -89.72M -6.09B -90.39M -631M -244M -3.11B -239M -234M -10.07B | -33.94M -29.81M -27.99M -25.63M -47.85M -3.25B -48.21M -336M -130M -1.66B -127M -125M -5.37B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
